DNA Instrument Sample Clauses

DNA Instrument. The Investor shall make available to the Company an automated DNA sequencing instrument, reasonably satisfactory to the Founder Stockholders, for use at the Osiris Facility. Use of such sequencing instrument by the Company will be on an equal-time basis with the Investor. A reagent budget for the sequencer will also be provided to the Company by the Investor for use by the Founder Stockholders in an amount not to exceed $75,000 per year. Commencing on October 4, 1994 and continuing until a sequencing instrument is operational at the Osiris Facility, the Investor will reimburse the Company for sequencing services provided at JHU's facilities which are requested by the Founder Stockholders, up to an annual amount of $75,000.